Review



compounds cell survival against dmso control  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol compounds cell survival against dmso control
    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple <t>concentrations</t> <t>(C3L,</t> 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average <t>DMSO</t> negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.
    Compounds Cell Survival Against Dmso Control, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 34 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Autophagy+Compound+Library/pmc13181845-63-3-32
    Average 94 stars, based on 34 article reviews
    compounds cell survival against dmso control - by Bioz Stars, 2026-11
    94/100 stars

    Images

    1) Product Images from "Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models"

    Article Title: Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models

    Journal: Digital Discovery

    doi: 10.1039/d5dd00190k

    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.
    Figure Legend Snippet: High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Techniques Used: Sample Throughput, Phenotypic Assay, Screening, Derivative Assay, Multiplex Assay, Cell Painting, Negative Control, Concentration Assay, Sensitivity, Fluorescence Microscopy

    Related Articles

    other:

    Article Title: FSH inhibits mitophagy via the mTOR/TFEB axis to preserve mitochondrial function in goat Sertoli cells.
    Article Snippet: Sertoli cells sustain spermatogenesis by providing metabolic and structural support to germ cells.. However, how endocrine signals regulate mitochondrial quality control, particularly mitophagy, in Sertoli cells remains unclear.. Here, we investigated the role of follicle-stimulating hormone (FSH) in modulating mitophagy and mitochondrial function in primary goat Sertoli cells.

    Article Title: Loss of Galectin-3 in the epidermis exacerbates psoriasis pathogenesis via inhibiting autophagy.
    Article Snippet: Aims: Galectin-3 (Gal3) is linked to psoriasis pathophysiology, however, the detailed mechanism of Gal3 involved in this course still needs further addressing.. This study aimed to elucidate the role of Gal3 in psoriasis.. Materials and methods: Imiquimod (IMQ)-induced psoriasis model in wild-type (WT) as well as Gal3 knockout (Gal3 /− ) mice were established to investigate the impact of Gal3 expression on the development of psoriasis.

    Article Title: MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis.
    Article Snippet: A range of reagents was procured from various suppliers, including KRAS G12C inhibitors such as fulzerasib (#T73190, TargetMol, Boston, Massachusetts, USA), garsorasib (#E1578, Selleck, Shanghai, China), sotorasib (#T8684, TargetMol), and adagrasib (#T8369, TargetMol); Mitogen-activated protein kinase (MAPK) pathway inhibitors including trametinib (#T2125, TargetMol) and SCH772984 (#T6066, AR TIC LE IN PR ES S TargetMol); the pan-RAS inhibitor RMC-7977 (#T81263, TargetMol); ferroptosis inducers, including RSL3 (#R302648, Aladdin, Shanghai, China) and Imidazole ketone erastin (IKE) (#T5523, TargetMol); as well as other inhibitors of cell death such as ferrostatin-1 (fer-1) (#T6500, TargetMol), deferoxamine (DFO) (#T1637, TargetMol), Z-VAD-FMK (Z-VAD) (#T7020, TargetMol), and necrosulfonamide (necro) (#T6904, TargetMol).

    Saline:

    Article Title: ENPP1-dependent USP2 ubiquitination governs SQSTM1-mediated autophagy-dependent ferroptosis in trophoblast cells and exacerbates placental dysfunction in gestational diabetes mellitus.
    Article Snippet: Downregulation of ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) has been implicated in autophagic cell death.. However, how ENPP1 regulates the interplay between autophagy and ferroptosis to maintain trophoblast homeostasis in the context of gestational diabetes mellitus (GDM) remains unclear.. To determine ENPP1’s role in autophagy-dependent ferroptosis and its contribution to GDM-related placental injury, clinical placental tissues, hyperglycemia-treated HTR8/SVneo trophoblasts, and streptozotocin-induced GDM mice were analyzed.

    Control:

    Article Title: Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models
    Article Snippet: .. The density of compounds' cell survival against DMSO control at the maximum concentration per library (C3L – 3 μM, KCGS – 1 μM, LOPAC – 3 μM, Prestwick – 10 μM, and TargetMol – 10 μM) shows a bimodal distribution for the TargetMol library, with more treatments that affect the cells' viability. ..

    Concentration Assay:

    Article Title: Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models
    Article Snippet: .. The density of compounds' cell survival against DMSO control at the maximum concentration per library (C3L – 3 μM, KCGS – 1 μM, LOPAC – 3 μM, Prestwick – 10 μM, and TargetMol – 10 μM) shows a bimodal distribution for the TargetMol library, with more treatments that affect the cells' viability. ..

    Analysis:

    Article Title: Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation.
    Article Snippet: PBMCs were either left untreated or treated with DMSO, 10 μM 16 EMBO Molecular Medicine © The Author(s) LOC14, or 10 μM CRID3 for 30 min, followed by stimulation with LPS for 6 h. Analysis of real-time cell death Real-time cell death assays were performed on an IncuCyte (Satorius, IncuCyte SX5). .. Propidium iodide (PI; Invitrogen, P3566) was added at the time of stimulation for cell death analysis. .. Propidium iodide (PI; Invitrogen, P3566) was added at the time of stimulation for cell death analysis.



    Similar Products

    99
    Illumina Inc illumina phix library
    Illumina Phix Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/pmc13750924-62-1-1
    Average 99 stars, based on 1 article reviews
    illumina phix library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc illumina phix control library
    Illumina Phix Control Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/pmc13755692-134-13-13
    Average 99 stars, based on 1 article reviews
    illumina phix control library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc thefinal libraries
    Thefinal Libraries, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1038_slash_s41467___026___78240___2-463-0-5
    Average 99 stars, based on 1 article reviews
    thefinal libraries - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc phix library
    Phix Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1007_slash_s40858___026___00851___3-111-16-18
    Average 99 stars, based on 1 article reviews
    phix library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Illumina Inc phix control library
    Phix Control Library, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/PhiX+Control+v3/10__1186_slash_s13287___026___05192___1-190-42-45
    Average 99 stars, based on 1 article reviews
    phix control library - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    TargetMol positive control article
    Positive Control Article, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/us12661357-97-0-11
    Average 97 stars, based on 1 article reviews
    positive control article - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    97
    TargetMol positive control group
    Positive Control Group, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pm42237667-88-1-24
    Average 97 stars, based on 1 article reviews
    positive control group - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    TargetMol compounds cell survival against dmso control
    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple <t>concentrations</t> <t>(C3L,</t> 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average <t>DMSO</t> negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.
    Compounds Cell Survival Against Dmso Control, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Autophagy+Compound+Library/pmc13181845-63-3-32
    Average 94 stars, based on 1 article reviews
    compounds cell survival against dmso control - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    97
    TargetMol positive control entry inhibitor
    (a) Percent inhibition of <t>entry</t> into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle <t>control.</t> Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 <t>positive-control</t> antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.
    Positive Control Entry Inhibitor, supplied by TargetMol, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/control+libraries/Bioactive+Compound+Library/pmc13270517-195-24-21
    Average 97 stars, based on 1 article reviews
    positive control entry inhibitor - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    Image Search Results


    High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Journal: Digital Discovery

    Article Title: Identification of drug candidates against glioblastoma with machine learning and high-throughput screening of heterogeneous cellular models

    doi: 10.1039/d5dd00190k

    Figure Lengend Snippet: High-throughput phenotypic assay screening of heterogeneous, patient-derived GBM cell lines. (A) High content phenotypic assay screening workflow on GBM cells. Five libraries were screened at multiple concentrations (C3L, 786 compounds at [0.003, 0.03, 0.3, 3] µm; KCGS, 187 compounds at [0.1, 1] µm; LOPAC, 1277 compounds at [0.5, 3] µm; Prestwick, 1276 compounds at [1, 10] µm; TargetMol-330, 330 compounds at [0.01, 0.1, 1, 10] µm). (B) Representative images of multiplex cell painting assay screen performed across the three main GBM cellular subtypes: classical (GCGR-E13, GCGR-E28), proneural (GCGR-E31, GCGR-E34), and mesenchymal (GCGR-E21, GCGR-E57). The cell painting stains shown are Hoechst (blue), phalloidin/WGA (green), and endoplasmic reticulum (red). (C) Density plots over all six GBM cell lines of the percentage of nuclei counts after compound treatment with respect to the average DMSO negative control (100%) per plate. After removal of duplicates, the dataset contains 3561 unique compounds. Colours correspond to each library (panel A), and only the highest concentration per library is shown. Cell line sensitivity to the compounds is variable across the cell lines; the bimodality displayed by the TargetMol library reveals a larger fraction of compounds that affect cell viability as compared to the other four libraries. (D) Density plots of the TargetMol library screen at all concentrations of cell line GCGR-E57 (top) and of cell line GCGR-E21 (bottom). The black dotted line represents the average DMSO negative control nuclei count. As the concentration increases, a larger number of compounds affects cell viability.

    Article Snippet: The density of compounds' cell survival against DMSO control at the maximum concentration per library (C3L – 3 μM, KCGS – 1 μM, LOPAC – 3 μM, Prestwick – 10 μM, and TargetMol – 10 μM) shows a bimodal distribution for the TargetMol library, with more treatments that affect the cells' viability.

    Techniques: Sample Throughput, Phenotypic Assay, Screening, Derivative Assay, Multiplex Assay, Cell Painting, Negative Control, Concentration Assay, Sensitivity, Fluorescence Microscopy

    (a) Percent inhibition of entry into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle control. Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 positive-control antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Journal: ACS Infectious Diseases

    Article Title: Computer-Aided Discovery of Small-Molecule Inhibitors of Pathogenic New World Arenavirus Entry and Replication

    doi: 10.1021/acsinfecdis.6c00138

    Figure Lengend Snippet: (a) Percent inhibition of entry into HEK 293T/T17 and (b) relative cell viability with 22f treatment against pseudotyped (PT) MLVs expressing NWA GPCs for JUNV, MACV, GTOV, or TCRV. Viral entry results represent the percent reduction in entry by 22f compared to the vehicle control. Cytotoxicity was determined in parallel by measuring the viability of treated cells using the CellTiter-Glo Luminescent Cell Viability Assay, with luminescence units normalized to the average vehicle control luminescence for each experiment. The 22f compound was well tolerated by cells, exhibiting a toxicity profile comparable to that of the ch128.1 positive-control antibody treatment. Data shown are the means ± SD from two separate experiments for each pseudotyped virus. **** p < 0.0001, *** p < 0.001, ** p < 0.01, * p < 0.05.

    Article Snippet: Follow-up pseudotyped LASV 22f viral entry inhibition assays and parallel cell viability assays were performed similarly, with the addition of LHF-535 (TargetMol) as a positive control entry inhibitor for OW arenavirus entry, which was prepared in the same vehicle control solution.

    Techniques: Inhibition, Expressing, Control, Cell Viability Assay, Positive Control, Virus